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Abstract: Nowadays, healthy eating is increasing the demand of functional foods by societies as
sources of bioactive products with healthy qualities. For this reason, we tested the safety of the
consumption of Borago officinalis L. and its main phenolic components as well as the possibility
of its use as a nutraceutical plant to help in cancer prevention. The in vivo Drosophila Somatic
Mutation and Recombination Test (SMART) and in vitro HL-60 human cell systems were performed,
as well-recognized methods for testing genotoxicity/cytotoxicity of bioactive compounds and plant
products. B. officinalis and the tested compounds possess antigenotoxic activity. Moreover, B. officinalis
wild type cultivar exerts the most antigenotoxic values. Cytotoxic effect was probed for both cultivars
with IC50 values of 0.49 and 0.28 mg¨mL´1 for wild type and cultivated plants respectively, as well
as their constituent rosmarinic acid and the assayed phenolic mixture (IC50 = 0.07 and 0.04 mM
respectively). B. officinalis exerts DNA protection and anticarcinogenic effects as do its component
rosmarinic acid and the mixture of the main phenolics presented in the plant. In conclusion, the
results showed that B. officinalis may represent a high value plant for pleiotropic uses and support its
consumption as a nutraceutical plant.
Keywords: Borago officinalis; health; safety; dietary bioactives; vegetables; SMART; HL-60;
cancer prevention
1. Introduction
Healthy eating is one of the most pursued objectives in today’s society. The increased demand
for food with protection properties against diseases has made herbal products a principal target for
industry requirements and government recommendations. In this sense, people usually search for
plants according to their well recognized benefits for human health, and most commonly herbal
components are considered commercial products [1]. However, reports that show protective effects in
some species are often conflicting or present variable results.
Borage (Borago officinalis L., Boraginaceae), also known as starflower, is a native annual plant in
the Mediterranean region that has been used since ancient times for culinary and medicinal purposes,
for the treatment of swelling and inflammation, respiratory complaints and melancholy (“I, Borage,
bring always courage,” translation of the old verse “Ego borago gaudia semper ago”) [2]. Also, health
properties such as anti-obesity, diuretic, emollient, lenitive, laxative, anti-anemic, menstrual analgesic
and antipyretic properties are recorded [3–5]. In this sense, borage leaves (>60% of the plant matter)
Nutrients 2016, 8, 48; doi:10.3390/nu8010048 www.mdpi.com/journal/nutrients
Nutrients 2016, 8, 48 2 of 16
are considered by industries as a by-product, so it could be used as an economic source of healthy
products [6].
Vegetable use of borage is common in Germany (as an ingredient in green sauce, made in
Frankfurt), Crete and in the Italian region of Liguria (to fill traditional ravioli pasta). Vegetable
borage is also very popular in the cuisine of the Spanish regions of Aragon and Navarra (i.e., boiled
and sautéed with garlic, served with potatoes). Borage is used by naturopathic practitioners in the
regulation of metabolism and the hormonal system, being considered a good remedy for premenstrual
syndrome and menopause symptoms, such as hot flashes [7,8]. In Iran, people make tea (Gol Gav
Zaban tea) to relieve colds, flu, bronchitis, rheumatoid arthritis, and kidney inflammation [9]. Recently,
interest in borage has been renewed because its seeds appear to be the richest known plant source of
gamma linolenic (all cis-6,9,12 octadecatrienoic) acid (GLA), which is an intermediate of indispensable
compounds in the body, such as prostaglandin E1 and its derivatives [10–14]. All these facts have
generated an increasing interest in B. officinalis production and researchers are now establishing the
best management practices in order to optimize crop performance [15,16]. Furthermore, borage is used
by industries as an antioxidant due to its bioactive compound content, i.e., phenolics, responsible for
most plant properties [17–19]. The phenolic content of edible parts (leaves and petioles) of B. officinalis
had been previously determined, with rosmarinic, syringic and sinapic acids being the major phenolics
in all plant growth stages [20–22]. These three compounds act as bioactive molecules and exert
antioxidant and anti-inflammatory properties [23–25]. Specially, rosmarinic acid is investigated and
employed by the food and pharmaceutical industries [26].
The complexity of plant composition and the human digestion process requires validated models
that represent this relation as closely and in a manner as valuable for research as possible. For this
reason, we have selected the in vivo Drosophila melanogaster and in vitro HL-60 human cancer cell system
as two complementary, sensitive, low-cost and rapid eukaryotic assays, able to detect the potential
mutagenic and carcinogenic effects of tested compounds [27–30].
We present the first report proving the antigenotoxic and anticarcinogenic properties of two
B. officinalis varieties (wild and cultivated) as well as of their major phenolics: rosmarinic, syringic and
sinapic acids. Moreover, the interaction between these bioactive compounds is tested, highlighting
their potential use and commercialization by industries for products with health benefits as
dietary bioactives.
2. Materials and Methods
2.1. Plant Material
Two Borago officinalis L. varieties were selected for this work: blue-flowered (BF, wild type,
accession Bo IAS 2008-07, collected in Córdoba in December 2009, Southern Spain) and white-flowered
(WF type, accession Bo IAS 2008-08, traditionally cultivated in Navarra in December 2009, Northern
Spain). These genotypes are part of a B. officinalis germplasm bank in the Institute of Sustainable
Agriculture (IAS-CSIC, Córdoba, Spain). Plants were grown on an experimental farm at the IAS
(N 37˝8', W 4˝8') wherein climate is typically Mediterranean, with an average annual rainfall of
650 mm. The soil is deep and sandy-loam, classified as a Typic Xerofluvent. Leaves and petioles from
5 plants of each variety were harvested when they reached the optimal stage to be consumed (55 days
after sowing), weighed, frozen (24 h at ´80 ˝C) and lyophilized with a freeze-drier Telstar model
Cryodos-50 (Telstar, Terrasa, Spain). After lyophilisation, dry material was weighed again, grounded
for about 20 s in a Janke and Kunkel Model A10 mill (IKA-Labortechnik, Staufen, Germany), mixed
and kept at room temperature and in darkness to preserve their properties until use.
2.2. Chemicals
The single compounds, rosmarinic (C18H16O8), syringic (C19H10O5) and sinapic (C11H12O5) acids,
were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Nutrients 2016, 8, 48 3 of 16
2.3. Drosophila Experiments
2.3.1. Fly Stocks and Crosses
The D. melanogaster system was selected for the determination of the safety of B. officinalis
consumption as a well-recognized method to analyze vegetable complex mixtures using SMART [31,32].
This test was used in order to evaluate the genotoxic and antigenotoxic activity of B. officinalis leaves
and petioles as well as their selected bioactive compounds [33]. This activity was measured by direct
visualization of the occurrence of recessive mutations in the wing hairs of two different D. melanogaster
strains. Flies from experiments carried these visible wing genetic markers: the flare (flr) strain flr3/ln
(3LR) TM3, Bds [34] and the multiple wing-hair (mwh) strain mwh/mwh [35]. The marker flare (flr3,
3_38.3) produces individual malformed hairs and the marker multiple wing hairs (mwh, 3_0.3) produces
multiple hairs per cell. Larvae used in treatments come from two types of crosses: the standard cross
with flr3/TM3, BdS females mated to mwh/mwh males and the reciprocal cross.
2.3.2. Larvae Treatments
Optimal fertile flies were anesthetized under CO2 narcotisation for cross selection and then
placed in new vials for fertilization. After that, hybrid eggs from crossing were collected over an
8 h period and emerged larvae (72 ˘ 4 h later) were cleaned up for a few seconds in sterile distilled
water to remove feeding medium rests [33]. For genotoxicity analysis (simple treatments), groups of
100 larvae were transferred into vials containing 0.85 g of Drosophila Instant Medium (Formula 4–24,
Carolina Biological Supply, Burlington, NC, USA) wetted with 4 mL of a mixture of distilled water
and increasing concentrations of samples: B. officinalis BF and WF (1.25, 2.5, and 5 mg¨mL´1), RO
(0.35, 0.7, 1.39 and 2.78 mM), SY (0.16, 0.32, 0.63 and 1.26 mM), SI (0.15, 0.29, 0.58 and 1.16 mM) and
the mixture of these three bioactive compounds at each concentration assayed individually. Bioactive
compound concentrations were chosen on the basis of their known content in B. officinalis species [11].
For antigenotoxicity analysis (combined treatments) the same number of vials were prepared but
treatment media were mixed with H2O2 0.12 M as mutagenic agent. Vials with the medium mixed
with distilled water or H2O2 (0.12 M) were used as negative and positive controls respectively. Larvae
were fed on these media until pupation (about 48 h). After emergence, resulting adult flies were
sacrificed under CO2 narcotisation and stored in a 70% ethanol solution in sterile water. Emerged
adults were counted for toxicity evaluation and transheterozygous wings (mwh flr`/mwh` flr3) were
mounted on microscope slides and wing hair mutations (spots) scored, using a photonic microscope
(Nikon) at 400ˆmagnification for genotoxicity and antigenotoxicity evaluation.
2.4. HL-60 Experiments
2.4.1. Cell Cultures
The human acute promyelocytic leukemia cell line HL-60 was routinely grown in suspension in
RPMI medium (Invitrogen, Madrid, Spain) containing glutamine (200 mM, Sigma-Aldrich, St. Louis,
MO, USA), antibiotics (100IU penicillin mL´1 and 100 µg streptomycin mL´1, Sigma-Aldrich) and
supplemented with 10% heat-inactivated foetal bovine serum (Linus, Cultek, Madrid, Spain) and
placed in an incubator (Shel Lab, Cornelious, OR, USA) with a 5% CO2 humidified atmosphere at
37 ˝C [36]. HL-60 cells were subcultured every 2–3 days to maintain logarithmic growth and they were
allowed to grow for 48 h before use [37]. Cultures were plated at a density of 12.5 ˆ 104 cells mL´1 in
40 mL culture flasks (25 cm2).
2.4.2. Cell Treatments
Cytotoxic activity was measured as growing inhibition or decreased viability on HL-60 cells
following a previous protocol modified by us [38]. For assays, cells were placed in 12-well culture
plates (1 ˆ 105 cells mL´1; final volume = 2 mL per well) and treated with different filtered (Millipore
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“non-pyrogenic”, “sterile-R”, 0.2 µm filter) RPMI solutions with the selected concentrations of B.
officinalis BF and WF plant samples (0.125, 0.25, 0.5, 1 and 2 mg¨mL´1), RO (0.07, 0.14, 0.28, 0.55, 1.1
and 2.2 mM), SY (0.03, 0.06, 0.13, 0.25, 0.5 and, 1 mM), SI (0.03, 0.06, 0.12, 0.23, 0.5 and, 1 mM) and the
mixture of these three bioactive compounds at each individually assayed concentration. Cells were
counted after 72 h treatment. Tested concentrations were calculated according to those used for in vivo
assays to equal the range of tested doses. Untreated cultures were used as negative control.
2.4.3. Trypan Blue Dye Exclusion Assay
Cell viability was determined by the Trypan Blue dye exclusion test. Cells were stained with an
equal volume of Trypan Blue commercial solution (Sigma-Aldrich) and counted using a hemocytometer
at room temperature under a light inverted microscope (AE30/31, Motic, Barcelona, Spain).
2.5. Statistical Analysis
The determination of Toxicity (T) of treatments in D. melanogaster was performed following this
formula [39]:
T “ pN˝ of emerging individuals in treatment{N˝ of emerging individuals in thenegative controlqˆ 100 (1)
Differences in D. melanogaster survival between treatments at each concentration with respect to
negative control were analyzed with a Chi-square test. This procedure was also performed for the
analysis of each simple treatment with their correspondent combined treatment.
For the evaluation of genotoxic effects, the frequencies of spots per fly of each treated series were
compared to the concurrent negative control for each class of mutational clone as well as between
simple and combined treatments for the same concentration comparisons. Spots were grouped into
three different categories: single (a small single spot corresponding to one or two cells exhibiting
the mwh phenotype), large (a large single spot corresponding to three or more cells showing mwh or
flr3 phenotypes) and twin (a large spot corresponding to three or more cells showing adjacent both
mwh and flr3 phenotypes). A multiple-decision procedure was used to categorize results as positive,
inconclusive or negative [40]. Inconclusive and positive results were evaluated by the non-parametric
U test of Mann, Whitney and Wilcoxon [41]. The inhibition percentage (IP) of genotoxicity was
calculated from the total frequencies of spots per wing, following this formula [42]:
IP “ pgenotoxin alone´ sample ` genotoxinqˆ 100{pgenotoxin aloneq (2)
Significant differences of IP for each treatment respect to the positive control were analyzed with
a Chi-square test.
Cytotoxic effect evaluation was determined after each culture incubation period, establishing a
growth curve and determining IC50 values by regression analysis of the curves. Viability estimated
regressions of leukemia cells are presented as a survival percentage with respect to controls at 72 h
growth and plotted as mean viability ˘ standard error of at least three independent replicas for each
treatment and concentration.
Statistical analyses were performed using a Microsoft 2007 Excel spreadsheet. The non-parametric
U test of Mann, Whitney and Wilcoxon was performed with the SPSS Statistic 17.0 software (SPSS, Inc.,
Chicago, IL, USA).
3. Results and Discussion
3.1. In Vivo Assays
Tables 1–3 show the results obtained in D. melanogaster experiments for edible leaves and petioles
of B. officinalis of the selected varieties, blue flowered (BF) and white flowered (WF), and their bioactive
compounds, rosmarinic (RO), syringic (SY) and sinapic (SI) acids. The negative controls produced
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mutation rates which fall into the normal range obtained in other laboratories, thus the data in
discussion comply with the expected spots per wing with no anomalous or borderline controls [43,44].
The positive control used in this study was hydrogen peroxide (H2O2). This oxidative mutagen has
been used in many mutation assays and it is known that an excess of H2O2 can influence the expression
of a high number of genes [45]. As previously reported, H2O2 affects D. melanogaster survival and
creates an excess of small single spots, with no significant induction of twin spot excess [29,39]. The
genotoxic results for H2O2 validate the assay as an appropriate system for screening between mutagens
(positive controls as H2O2) and non-mutagens (water controls or safe plants and bioactive compounds).
Table 1. Toxicity of Borago officinalis plant material, blue flowered (BF) and white flowered (WF), and
the bioactive compounds, rosmarinic (RO), syringic (SY) and sinapic (SI) acids.
Survival 1 % Treatments
Simple Combined 2 Simple Combined 2
H2O 100 H2O2 (0.12 M) 37.87 *
BF (mg¨mL´1) WF (mg¨mL´1)
1.25 100 52.44 *,‡ 1.25 97.78 33.33 *,‡
2.5 100 54 *,‡ 2.5 63.11 * 27.56 *,‡
5 82 * 86.89 * 5 71.33 * 17.33 *,‡
RO (mM) SY (mM)
0.35 48.44 * 49.56 * 0.16 39.78 * 31.11 *,‡
0.7 22.22 * 31.11 *,‡ 0.32 42.67 * 29.33 *,‡
1.39 33.33 * 45.56 *,‡ 0.63 31.11 * 20.44 *,‡
2.78 21.33 * 38.89 *,‡ 1.26 58.22 * 36.89 *,‡
SI (mM) RO + SY + SI (mM)
0.15 78.22 * 64 *,‡ a 3 48.67 * 24.44 *,‡
0.29 60.22 * 58.89 * b 55.11 * 34.67 *,‡
0.58 69.33 * 39.78 *,‡ c 74.44 * 57.78 *,‡
1.16 55.11 * 43.56 *,‡ d 44.89 * 53.78 *,‡
1 Survival expressed in percentage as total emerged adults of each treatment with respect to H2O control total
emerged adults; 2 Combined treatments using standard medium and 0.12 M H2O2; 3 Letters a–d correspond
to the lowest, two intermediate and highest concentrations respectively assayed for each single compound
once their mixture is assayed; * Significance levels with respect to the negative control (untreated, H2O) group
(p ď 0.05); ‡ Significance levels between simple and combined treatment for the same concentration comparisons
(p ď 0.05).
Table 2. Genotoxicity of Borago officinalis plant material: blue flowered (BF) and white flowered (WF);
and the bioactive compounds: rosmarinic (RO), syringic (SY) and sinapic (SI) acids.
Mutation Rate (Spots/Wing) Diagnosis 1
N˝ of Wings
Small Single
Spots 1–2 Cells
m = 2
Large Single
Spots >2 Cells
m = 5
Twin Spots
m = 5
Total Spots
m = 2
H2O 212 0.26 (54) 0.04 (8) 0.03 (5) 0.32 (67)
H2O2 (0.12 M) 168 0.60 (94) + 0.07 (11) ´ 0.06 (4) ´ 0.65 (109) +
BF (mg¨mL´1)
1.25 40 0.13 (5) ´ 0.03 (1) ´ 0.05 (2) ´ 0.20 (8) ´
2.5 54 0.22 (12) ´ 0.06 (3) ´ 0.02 (1) ´ 0.30 (16) ´
5 66 0.29 (19) ´ 0.03 (2) ´ 0.05 (3) ´ 0.36 (24) ´
WF (mg¨mL´1)
1.25 66 0.26 (17) ´ 0.03 (2) ´ 0.05 (3) ´ 0.33 (22) ´
2.5 50 0.26 (13) ´ 0.08 (4) ´ 0.02 (1) ´ 0.36 (18) ´
5 90 0.36 (32) ´ 0.02 (2) ´ 0.01 (1) ´ 0.39 (35) ´
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Table 2. Cont.
Mutation Rate (Spots/Wing) Diagnosis 1
N˝ of Wings
Small Single
Spots 1–2 Cells
m = 2
Large Single
Spots >2 Cells
m = 5
Twin Spots
m = 5
Total Spots
m = 2
RO (mM)
0.35 16 0.38 (6) ´ 0 0 0.38 (6) ´
0.7 34 0.21 (7) ´ 0 0.06 (2) ´ 0.26 (9) ´
1.39 22 0.18 (4) ´ 0 0.05 (1) ´ 0.23 (5) ´
2.78 38 0.16 (6) ´ 0.05 (2) ´ 0 0.21 (8) ´
SY (mM)
0.16 40 0.30 (12) ´ 0.05 (2) ´ 0.03 (1) ´ 0.38 (15) ´
0.32 30 0.20 (6) ´ 0.07 (2) ´ 0 0.27 (8) ´
0.63 48 0.19 (9) ´ 0.02 (1) ´ 0 0.21 (10) ´
1.26 32 0.22 (7) ´ 0.06 (2) ´ 0 0.28 (9) ´
SI (mM)
0.15 24 0.38 (9) ´ 0.04 (1) ´ 0.04 (1) ´ 0.46 (11) ´
0.29 32 0.39 (12) ´ 0.10 (3) ´ 0 0.48 (15) ´
0.58 30 0.33 (10) ´ 0.07 (2) ´ 0 0.40 (12) ´
1.16 40 0.23 (9) ´ 0.03 (1) ´ 0.03 (1) ´ 0.28 (11) ´
RO + SY + SI (mM)
a 2 26 0.15 (4) ´ 0 0.04 (1) ´ 0.19 (5) ´
b 34 0.12 (4) ´ 0.03 (1) ´ 0 0.15 (5) ´
c 32 0.22 (7) ´ 0.13 (4) + 0 0.34 (11) ´
d 22 0.41 (9) ´ 0.05 (1) ´ 0 0.45 (10) ´
1 Statistical diagnoses: + (positive) and ´ (negative) [40,41]. Significance levels α = β = 0.05, one-sided
test without Bonferroni correction; 2 Letters a–d correspond to the lowest, two intermediate and highest
concentrations respectively assayed for each single compound once their mixture is assayed.
Table 3. Antigenotoxicity of Borago officinalis plant material: blue flowered (BF) and white flowered
(WF); and the bioactive compounds: rosmarinic (RO), syringic (SY) and sinapic (SI) acids.
Mutation Rate (Spots/Wing) Diagnosis 1
N˝ of Wings
Small Single
Spots 1–2 Cells
m = 2
Large Single
Spots >2 Cells
m = 5
Twin Spots
m = 5
Total Spots
m = 2
H2O 212 0.26 (54) 0.04 (8) 0.03 (5) 0.32 (67)
H2O2 (0.12 M) 168 0.60 (94) + 0.07 (11) – 0.06 (4) – 0.65 (109) +
BF (mg¨mL´1)
1.25 30 0.13 (4) ´ 0.03 (1) ´ 0 0.17 (5) ´
2.5 34 0.24 (8) ´ 0.03 (1) ´ 0 0.26 (9) ´
5 18 0.17 (3) ´ 0.06 (1) ´ 0 0.23 (4) ´
WF (mg¨mL´1)
1.25 10 0.30 (3) ´ 0.10 (1) ´ 0 0.40 (4) ´
2.5 28 0.32 (9) ´ 0 0 0.32 (9) ´
5 24 0.25 (6) ´ 0.04 (1) ´ 0 0.29 (7) ´
RO (mM)
0.35 30 0.17 (5) ´ 0 0 0.17 (5) ´
0.7 40 0.35 (14) ´ 0.08 (3) ´ 0.03 (1) ´ 0.45 (18) ´
1.39 22 0.14 (3) ´ 0.14 (3) ´ 0 0.27 (6) ´
2.78 52 0.21 (11) ´ 0 0.04 (2) ´ 0.25 (13) ´
SY (mM)
0.16 22 0.23 (5) ´ 0 0 0.23 (5) ´
0.32 10 0.30 (3) ´ 0 0 0.30 (3) ´
0.63 32 0.28 (9) ´ 0 0 0.28 (9) ´
1.26 22 0.32 (7) ´ 0 0 0.32 (7) ´
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Table 3. Cont.
Mutation Rate (Spots/Wing) Diagnosis 1
N˝ of Wings
Small Single
Spots 1–2 Cells
m = 2
Large Single
Spots >2 Cells
m = 5
Twin Spots
m = 5
Total Spots
m = 2
SI (mM)
0.15 12 0.42 (5) ´ 0 0 0.42 (5) ´
0.29 8 0.25 (2) ´ 0 0 0.25 (2) ´
0.58 22 0.27 (6) ´ 0.09 (2) ´ 0.05 (1) ´ 0.41 (9) ´
1.16 28 0.25 (7) ´ 0.04 (1) ´ 0 0.29 (8) ´
RO + SY + SI (mM)
a 2 38 0.29 (11) ´ 0 0 0.29 (11) ´
b 26 0.27 (7) ´ 0.15 (4) + 0 0.42 (11) ´
c 17 0.18 (3) ´ 0 0 0.18 (3) ´
d 12 0.25 (3) ´ 0.08 (1) ´ 0 0.33 (4) ´
1 Statistical diagnoses: + (positive) and ´ (negative) [40,41]. Significance levels α = β = 0.05, one-sided
test without Bonferroni correction; 2 Letters a–d correspond to the lowest, two intermediate and highest
concentrations respectively assayed for each single compound once their mixture is assayed.
3.1.1. Toxicity Assays
Table 1 summarizes the toxicity results obtained for analyzed samples expressed as percentage of
emerged adults from treatment compared with the emerged adults from the negative control (survival
control corrected).
All treatments at all assayed concentrations significantly affected D. melanogaster survival except
plant samples of B. officinalis BF at concentrations 1.25 and 2.5 mg¨mL´1 and B. officinalis WF at
1.25 mg¨mL´1. The highest concentration of B. officinalis BF reduced the D. melanogaster survival to less
than 20%. Intermediate and highest B. officinalis WF assayed concentrations decreased D. melanogaster
survival to 63.11% and 71.33% respectively. Regarding borage toxicity, the American Herbal Products
Association’s Botanical Safety Handbook recommends Borago ssp. leaf consumption sporadically due
to their pyrrolizidine alkaloid content [46,47]. However, current revisions of Borago ssp. properties
suggest that the complex bioactive compound leaf composition of this species is more beneficial than
harmful for human health because of its phenolic content [3]. This fact could explain the difference
we have found between B. officinalis BF and WF toxicity levels. On average, the bioactive compounds
reduced D. melanogaster larval survival by around 50% (LD50), normal values for toxicity assays and
no dose effect was observed. RO showed the largest reduction in survival, with the highest RO
concentration being the most toxic treatment (21.33%). Other authors have also found RO toxicity by
oral administration [48]. However, these authors recommend the use of RO in human inflammatory
diseases because of its protective effect in the stomach unlike commonly used anti-inflammatory
products that possess serious disadvantages for human health. The addition of H2O2 to the medium
in combined treatments contributed to reducing D. melanogaster larval survival in all samples when
compared to simple treatments, with the exception of the highest B. officinalis BF concentration as
well as all RO assayed concentrations and highest mixture concentration. These treatments had a
protective effect against H2O2 damage (detoxification), interfering with H2O2 oxidative action and
slightly increasing D. melanogaster larval survival. Nevertheless, only in the case of RO treatments this
effect was significant. Contrarily, the application of RO mixed with SY and SI (mixture treatment) did
not present any protective additive effects with the exception of highest tested concentration. Thus, the
addition of H2O2 to the medium in mixture treatments reduced D. melanogaster survival to a greater
degree than applying RO alone in combined treatments. However, the mixture survival ended up
quite similar to RO survival in combined treatments (survival average of 42.67 and 41.28 respectively).
Previous reports showed that the B. officinalis beneficial effect on health depends on the composition of
phenolics having synergic effects [20,49]. This fact could explain why the mixture of selected bioactive
compounds did not exert the same protective effects as RO when it is added alone to a larvae feeding
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medium in combined treatments. B. officinalis WF treatments resulted in the highest survival reduction
(average of 66.32%) when combining with H2O2. Moreover, the combined (H2O2) treatment at the
highest B. officinalis WF concentration produced the highest reduction of D. melanogaster survival
decreasing this value to 17.33%. The H2O2 toxic effect was enhanced also by lowest and intermediate
B. officinalis BF concentrations with an average survival reduction of ~50%.
3.1.2. Genotoxicity Assays
Table 2 summarizes the genotoxicity results obtained in the Somatic Mutation and Recombination
Test (SMART) as total mutations per wing observed in treatments with B. officinalis plant and bioactive
compound samples.
It is remarkable that no concentration of plant samples was significantly different from the
negative control, but contrarily, some of the treatments showed lower mutation rates (from 0.20 to
0.30) than the negative control (0.32). Although a healthy and non-genotoxic effect of many herbal
products is generally expected, it is necessary to empirically check this assumption for parts of the
plants that are usually consumed [1,50]. This result is also displayed for plant phenolic products
for which pharmacological potential has been widely tested but no complete understanding of their
mechanism of action has been elucidated [51].
At present, very little is known about the lack of genotoxicity of B. officinalis plants with no
direct work reporting genotoxic effects, although a previous work determined the genotoxicity of
pirrolizidine alkaloids (compounds present in B. officinalis plants) using SMART [52]. This work
classified pirrolizidine compounds as genotoxic but this effect varied widely depending on their
chemical structures. Similarly to the plant sample results, the main bioactive constituents of B. officinalis,
RO, SY and SI phenols, were not mutagenic in the Drosophila wing spot test as expected from the
negative results for the plant. A multitude of beneficial biological activities have been described
for RO (astringent, antioxidative, anti-inflammatory, antimutagen, antibacterial and antiviral), so
the non-mutagenic results obtained in the wing spot test were expected [24]. Our results also agree
with those of Pereira et al. [53] that showed no genotoxic effect of RO (doses of 2 and 8 mg¨kg´1)
using the comet assay in brain tissue and peripheral blood in rats. In conclusion, B. officinalis plants
and their selected components did not exert any DNA damage on the mwh/flr eukaryotic system of
D. melanogaster.
3.1.3. Antigenotoxicity Assays
In this work we present results on the antigenotoxic activity of B. officinalis leaves and petioles
which could be considered as a health benefits index. Our results for combined treatments in the
SMART, showed in Table 3, account for the desmutagenic activity of the selected substances when
assayed against H2O2.
The inhibition percentage (IP) ranged between 30.77% and 73.85% in tested samples. The highest
detoxification potential appeared in the highest B. officinalis BF concentration (Figure 1a) as well as RO
at 0.35 mM (Figure 2a). The lowest detoxification potential corresponded to RO treatments at 0.7 mM
(Figure 2a). All these samples corresponded to combined treatments (adding H2O2 to samples). No
dose effect relationship was observed. The detoxifying ability of highest B. officinalis BF and lowest RO
assayed concentrations against mutations produced by H2O2 can be explained by the direct interaction
of phenols contained in the plants which act as scavengers of reactive oxygen species before the larvae
uptake and H2O2 reaches the DNA [54]. In this respect, RO, SY and SI behaved as desmutagens with a
high antioxidative capacity, which has also been shown when they are extracted from borage defatted
seeds [55].
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Figure 2. Antigenotoxic activity of Borago officinalis bioactive compounds: (a) RO; (b) SY; (c) SI and
(d) mixture (RO + SY + SI) expressed as mutation frequency c rr cted to c trol. Strength of inhibition
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assayed for each single compound once their mixture is assayed. * Significance levels with respect to
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Our results for RO bioactive compound are in accordance with prior reports showing its protective
effect against H2O2 damage in other in vivo systems like rats as well as in vitro systems [56,57]. This
antigenotoxic effect has also been demonstrated against the DNA damage brought on by the mutagen
ethyl methanesulfonate in males from D. melanogaster using the sex-linked recessive lethal (SLRL)
test [58]. The other phenolics assayed, SY and SI, possess lower antigenotoxic activity with SI being the
least effective in reducing mutations induced by H2O2 (Figure 2b,c). In accordance with these results,
SI has been recently used in order to determine its genotoxic/antigenotoxic activity in the V79 cell
line [59]. This phenolic was found to be antigenotoxic but in a way that depends on the dose, with the
lower concentrations (below 2 mM, as our assayed concentrations) being those that significantly reduce
DNA damage. As discussed for toxicity results, no additive effect in phenolic mixture was found in
any assayed concentration (Figure 2d). In this sense, phenolic borage content varies depending on
the plant stage, tested phenolics being the major bioactive constituents during plant growth [20,49].
This fact might suggest that the antigenotoxic effect found in our samples corresponds to a specific
phenolic or the addition of each phenolic effect. However, our results showed that phenolic effects are
not additives but synergic.
3.2. In Vitro Assays
Cytotoxicity Assays
The human acute promyelocytic leukemia cell line HL-60 has been used as a model on a wide
variety of substances that are candidates to be used as anticarcinogens and has proved to be a robust
test system for pilot screening experiments [30,39,60]. That is why we have selected this system to
elucidate the inhibitory capacity of tumour growth for the different samples studied. Our results are
shown in Figure 3 as the relative HL-60 growth rate with different concentrations of B. officinalis BF
and WF plant samples and their main active components (RO, SY and SI) regarding their concurrent
control cultures.
A dose-response curve was observed for B. officinalis BF and WF plant material (Figure 3a,b)
which exhibited IC50 values of 0.49 and 0.28 mg¨mL´1 respectively. This cytotoxic effect of borage was
also found in the Vero line of African green monkey kidney cells with an IC50 value of 0.2 mg¨mL´1
(similar to that obtained for our borage WF samples) [61].
In the case of phenolic compounds, the IC50 could only be determined for RO (0.07 mM) and
mixture (0.04 mM of RO equivalent units) samples with a marked slope in the case of phenol mixture.
Interestingly, no viable cells could be detected when RO was added to the cell medium (alone or in the
mixture) at concentrations over 0.55 mM (Figure 3c,f). Other studied cancer cell lines have been shown
to be more sensitive to RO exposure than HL-60 cells, a fact that enhances the disease prevention
properties of RO [62,63]. Also, in vivo studies in mice conclude that the RO anticarcinogenic activity
is related to the activity of this phenol in inhibiting inflammation and scavenging reactive oxygen
species [64]. In our experiments, the phenols SY and SI did not affect HL-60 growth (Figure 3d,e).
The lack of cytotoxicity in HL-60 experiments that we have found for SY is in accordance with
previous determination that indicated no cytotoxic effect of SY in extracts of Elaphomyces granulates at
concentrations up to ~31 µg¨mL´1 using this cell line [65]. Moreover, Fabiani et al. [66] found that SY
did not induce apoptosis in HL-60 cell when is applied to the cell medium at a concentration of 0.1 mM.
It has been reported that SI biotransformation by plant peroxidases results in an anticarcinogenic effect
from its derivates in HL-60 cells [67]. This fact could explain the difference that we found between
its antigenotoxic effect in D. melanogaster individuals and the lack of SI cytotoxicity in HL-60 cells, SI
derivates being responsible for healthy actions instead of the phenol. As in the case of antigenotoxicity
experiments, the cytotoxic effect of the mixture did not correspond to the addition of each individually
assayed phenolic. Moreover, the fact that mixture samples presented the highest anticarcinogenic
effect proves that the phenolic mixture produces a synergic healthy effect.
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 Figure 3. Survival of HL-60 cultures treated with different concentrations of: Borago officinalis
(a) blue flowered (BF) and (b) white flowered (WF) plant material; and bioactive compounds: (c) RO;
(d) SY; (e) SI and (f) mixture (RO + SY + SI; italic letters from a–f correspond to the concentrations
respectively assayed for each single compound once their mixture is assayed.). Survival estimated
regressions are plotted as percentages with respect to the control counted from at least three
independent experiments (mean ˘ SD).
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4. Conclusions
We have provided a primer on antigenotoxicity and tumoricide activities of edible parts (leaves
and petioles) of two borage varieties and some of its bioactive principles. The in vivo assays showed
their safe use for human consumption and their antigenotoxicity potency, supporting their protective
DNA damage activity and consequently their health benefits. Our results in the in vitro assays highlight
B. officinalis fresh plant use as a nutraceutical plant and as a potential source of dietary bioactives with
an outstanding anticarcinogenic activity. In this sense, B. officinalis is a desirable Mediterranean plant
adapted to the European climate and a good source of pharmaceutical products, which has made
B. officinalis a fashionable topic in plant research. Borage breeders have to take this eventual insight as
a unique opportunity. Exploitation of this vegetable could be focused on a dual perspective: on the
one hand, these cultivars could be partially used for bioactive resources and on the other, as a part
for growing a unique plant. The wide spread of B. officinalis cultivars for industrial purposes should
be used to advise world markets about the pleiotropic uses of this vegetable, not only as a source of
products but also as a nutraceutical fresh-consumed plant.
In brief, the varieties studied here show that B. officinalis could be put on the table not as a
silent partner with other vegetables but as something more than a salad due to its protective and
chemopreventive activities.
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BF Borago officinalis blue-flowered
CO2 carbon dioxide
DNA deoxyribonucleic acid
flr flare
H2O2 hydrogen peroxide
HL-60 human acute promyelocytic leukemia cell line
IC50 half maximal inhibitory concentration
IP inhibition percentage
LD50 median lethal dose
mwh multiple wing-hair
RO rosmarinic acid
SI sinapic acid
SMART somatic mutation and recombination test
SY syringic acid
T toxicity
WF Borago officinalis white-flowered
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